We analyzed its expression in lung cancer samples, and immunohistochemistry results from the HPA database showed a decrease in ZBTB16 protein levels in lung cancer tissues, consistent with previous results (Figures 5A, B). This evidence concerns the gene ZBTB16 and lung cancer.